ATLAS
Live / Applied — Suspended — suspension letter mailed (as of 09 Feb 2026)
What this means for you
Not registered yet, but its 18 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99401036
- Mark type
- Stylized text
- Filed
- 18 Sept 2025
- Attorney of record
- Daniel H. Landau
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable computer software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable cloud-computing software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use, all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoring
- Class 035 — Advertising and business services: Business administration services in the field of population-level healthcare
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Cloud computing featuring software for use with value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Software as a service (SAAS) services featuring software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Providing on-line non-downloadable software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare, all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use; all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoring
Owner
- Innovaccer Inc., San Francisco, CA, US
Prosecution history
- 09 Feb 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 09 Feb 2026 — LETTER OF SUSPENSION E-MAILED
- 09 Feb 2026 — SUSPENSION LETTER WRITTEN
- 06 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — NON-FINAL ACTION WRITTEN
- 03 Oct 2025 — ASSIGNED TO EXAMINER
- 18 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Sept 2025 — NEW APPLICATION ENTERED